{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:01:17Z","timestamp":1695618077972},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.eimc.2016.02.001","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T14:45:49Z","timestamp":1457707549000},"page":"174-178","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["HIV-1 p24 and CD4 + T cell count during boosted protease-inhibitor monotherapy in HIV-infected patients"],"prefix":"10.1016","volume":"35","author":[{"given":"Omar Jesus","family":"Benmarzouk-Hidalgo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"Torres-Cornejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Gutierrez-Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pompeyo","family":"Viciana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Fernando","family":"L\u00f3pez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2016.02.001_bib0130","doi-asserted-by":"crossref","first-page":"e22003","DOI":"10.1371\/journal.pone.0022003","article-title":"Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis","volume":"6","author":"Mathis","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eimc.2016.02.001_bib0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-6405-10-3","article-title":"Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting","volume":"10","author":"Arribas","year":"2013","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.eimc.2016.02.001_bib0140","first-page":"1","article-title":"Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsets","volume":"73","author":"Andrieu","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.eimc.2016.02.001_bib0145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/ije\/27.5.897","article-title":"Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200\/microL. SEROCO & HEMOCO Study Group","volume":"27","author":"Carr\u00e9","year":"1998","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eimc.2016.02.001_bib0150","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1086\/315366","article-title":"Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement","volume":"181","author":"Ledergerber","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2016.02.001_bib0155","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1086\/322045","article-title":"Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia","volume":"184","author":"Sabin","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2016.02.001_bib0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4321\/S0212-71992001001000003","article-title":"Supervivencia y progresi\u00f3n de la enfermedad en 251 pacientes con infecci\u00f3n por el VIH-1: Estudio del ant\u00edgeno p24 y de la carga viral como marcadores pron\u00f3stico. Su valor a los 4 a\u00f1os de seguimiento","volume":"18","author":"Rubio Caballero","year":"2001","journal-title":"An Med Interna (Madrid)"},{"key":"10.1016\/j.eimc.2016.02.001_bib0165","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1086\/343807","article-title":"Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease","volume":"186","author":"Sterling","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2016.02.001_bib0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00126334-200307010-00002","article-title":"HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy","volume":"33","author":"Sch\u00fcpbach","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2016.02.001_bib0175","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.qai.0000181281.75670.56","article-title":"HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4 (+) T cell loss","volume":"40","author":"Sch\u00fcpbach","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2016.02.001_bib0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/QAI.0b013e31817dc3d1","article-title":"p24 as a predictor of mortality in a cohort of HIV-1-infected adults in rural Africa","volume":"48","author":"Erikstrup","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2016.02.001_bib0185","doi-asserted-by":"crossref","first-page":"e907","DOI":"10.1016\/j.ijid.2013.05.003","article-title":"Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis","volume":"17","author":"Wejse","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.eimc.2016.02.001_bib0190","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1128\/AAC.00315-13","article-title":"Lopinavir plasma concentrations and virological outcome with lopinavir\u2013ritonavir monotherapy in HIV-1-infected patients","volume":"57","author":"Lopez-Cortes","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2016.02.001_bib0195","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3851\/IMP2722","article-title":"Darunavir Cmin and ritonavir-boosted darunavir monotherapy outcome in HIV-infected patients","volume":"19","author":"Gutierrez-Valencia","year":"2014","journal-title":"Antivir Ther"},{"key":"10.1016\/j.eimc.2016.02.001_bib0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/QAD.0000000000000060","article-title":"Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir\/ritonavir monotherapy","volume":"28","author":"Torres-Cornejo","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2016.02.001_bib0205","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jmv.20655","article-title":"Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART","volume":"78","author":"Sch\u00fcpbach","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.eimc.2016.02.001_bib0210","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1056\/NEJM199905273402102","article-title":"Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy","volume":"340","author":"Furtado","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2016.02.001_bib0215","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/324002","article-title":"Human immunodeficiency virus type 1 RNA in peripheral blood mononuclear cells of patients receiving prolonged highly active antiretroviral therapy","volume":"184","author":"Zhang","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2016.02.001_bib0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/135965350200700203","article-title":"Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts","volume":"7","author":"Fischer","year":"2002","journal-title":"Antivir Ther"},{"key":"10.1016\/j.eimc.2016.02.001_bib0225","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/978-1-4614-0980-9_20","article-title":"Assembly and architecture of HIV","volume":"726","author":"Ganser-Pornillos","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.eimc.2016.02.001_bib0230","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2217\/17435889.3.3.293","article-title":"Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method","volume":"3","author":"Kim","year":"2008","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.eimc.2016.02.001_bib0235","doi-asserted-by":"crossref","first-page":"11407","DOI":"10.1128\/JVI.01211-09","article-title":"High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment","volume":"83","author":"Gonzalez","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.eimc.2016.02.001_bib0240","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/aid.2014.0299","article-title":"Higher activation in CD4(+) T cells but similar viral control among HIV\/Hepatitis C virus-coinfected patients on a simplification monotherapy","volume":"32","author":"BenMarzouk-Hidalgo","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.eimc.2016.02.001_bib0245","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"Hunt","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2016.02.001_bib0250","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/QAD.0000000000000815","article-title":"Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia","volume":"30","author":"Guihot","year":"2016","journal-title":"AIDS"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X16000689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X16000689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:12:56Z","timestamp":1655251976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X16000689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0213005X16000689"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2016.02.001","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 p24 and CD4+ T cell count during boosted protease-inhibitor monotherapy in HIV-infected patients","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2016.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}